Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Let's not forget..

A fair price is not based on the current share price but on the potential valuation of assets.

If TPL tried to "squeeze it out" not only would Alliacense be in contractual breach, more importantly TPL would be hurting themselves.

Would Moore want "his" MMP Portfolio made obvious? Think about it.

For once, "what is good for the real players" is also good for "the shareholders" as far as the patents are concerned, in my very humble opinion. They need revalidation just as much as the shareholders.





Be well

Share
New Message
Please login to post a reply